| |
DAY 1 -
Tuesday, 19 February 2013 (no CME
available) |
|
|
16:00 |
Registration &
Speaker upload available |
|
|
|
|
|
|
20:00 |
Opening
Reception & Dinner |
|
| |
|
|
|
| |
DAY 2 - Wednesday, 20
February 2013
(6.5 CME available) |
|
|
07:00 |
Registration
& Speaker upload available |
|
|
08:30 |
Welcome |
|
|
|
In Memoriam: Marion Stubbs, D.Phil. |
|
|
|
|
|
|
|
Session 1: Focus on MR/PET
in Cancer Diagnosis & Treatment |
|
|
Moderator:
Ambros J. Beer, M.D. |
|
|
09:00 |
Advances in
Hybrid MR-PET Imaging at 3T & 9.4T for Cancer Diagnostics in
Humans |
N. Jon Shah,
Ph.D.
Forschungszentrum Jülich GmbH
Jülich, Germany |
|
09:30 |
PET/MR in
Oncology: Potential, Problems & Perspectives |
Ambros J. Beer,
M.D.
Technische Universität München
Munich, Germany |
|
|
|
|
|
|
Oral Session –
Proffered Papers |
|
|
10:00 |
Assessment of
Treatment Response in Patients with
Glioblastoma using Dynamic [18F] Fluoroethyl-L-Tyrosine PET in Comparison to MRI |
Karl-Josef Langen,
M.D.
Institute of
Neuroscience & Medicine
Jülich, Germany |
|
10:15 |
Quantitative
Water Content, T2* & Susceptibility Mapping by MRI in Brain
Tumour Tissue Defined by FET-PET |
Ana-Maria
Oros-Peusquens, Ph.D.
Research Centre
Jülich
Jülich, Germany |
|
10:30 |
Break & Speaker
upload available |
|
|
|
|
|
|
|
Session 2: Focus on MR/Optical
in Cancer Diagnosis & Treatment |
|
|
Moderator:
Kristine Glunde, Ph.D. |
|
|
11:00 |
Cancer Diagnosis
& Treatment Monitoring with MR/Diffuse Optics
|
Regine Choe,
Ph.D.
University of Rochester
Rochester, NY, USA |
|
11:30
|
MRI-Guided
Optical Spectroscopy for Quantifying Tumor Biomarkers
- permission
withheld |
Scott C. Davis,
Ph.D.
Dartmouth College
Hanover, NH, USA |
|
|
|
|
|
|
Oral Session –
Proffered Papers |
|
|
12:00 |
Multimodal Cell
Tracking of a Spontaneous Metastasis Model: Comparison
between MRI, Electron Paramagnetic Resonance &
Bioluminescence |
Bernard Gallez,
Ph.D.
Université
Catholique de Louvain
Brussels,
Belgium |
|
12:15 |
Cerenkov Imaging
& Imaging Fluorescent Choline Kinase Inhibitors |
E. Jim Delikatny,
Ph.D.
University of Pennsylvania
Philadelphia, PA, USA |
|
12:30 |
Lunch & Speaker
upload available |
|
|
|
|
|
|
|
Session 3:
Inter-Modality Image Registration & Multidimensional Dataset
Analysis |
|
|
Moderator:
James O’Connor, Ph.D., F.R.C.R. |
|
|
14:00 |
Tools for
Quantitative Correlation, Convergence of Multi-Scale,
Multi-Modal Data: Case Studies in Prostate, Breast Cancer
|
Anant Madabhushi,
Ph.D.
Case Western Reserve University
Cleveland, OH, USA |
|
14:30 |
3D Multiscale MR,
Optical & MSI Image Fusion & Data Mining in Breast Tumor
Models |
Lu Jiang, Ph.D.
Johns Hopkins University School of Medicine
Baltimore, MD, USA |
|
|
|
|
|
|
Oral Session –
Proffered Papers |
|
|
15:00 |
Unraveling
Proteins in a Breast Tumor Model by Combining Magnetic
Resonance Spectroscopic Imaging with Mass Spectrometric
Imaging |
Lu Jiang, Ph.D.
Johns Hopkins University School of Medicine
Baltimore, MD, USA |
|
15:15 |
A Two-Stage
Model for Studying Brain Tumour Perfusion & Surrounding
Vasculature using Arterial Spin Labeling |
Patrick W.
Hales, Ph.D.
University
College London
London, England, UK |
|
15:30 |
Break & Speaker
upload available |
|
|
|
|
|
|
|
Session 4: Multimodal
MRI of the Tumor Microenvironment |
|
|
|
Moderator: E.
Jim Delikatny, Ph.D. |
|
|
16:00 |
Longitudinal
Imaging of Tumor pO2 to Examine Sunitinib-Induced Vascular
Renormalization |
Murali Krishna,
Ph.D.
National Institutes of Health
Bethesda, MD, USA |
|
16:30 |
The Role of
Hyperpolarized 13C MRI as Part of Multimodality Imaging of
Tumors |
Ferdia A.
Gallagher, Ph.D., F.R.C.R.
University of Cambridgee
Cambridge, England, UK |
|
|
|
|
|
|
Oral Session –
Proffered Papers |
|
|
17:00 |
Hyperpolarized
MR & PET: Characterizing Metabolism & Microenvironment using
Co-Polarized [1-13C] Pyruvate & 13C Urea, with 18F FDG in a
Murine Model of Prostate Cancer |
Kayvan R.
Keshari, Ph.D.
University of
California, San Francisco
San Francisco,
CA, USA |
|
17:15 |
Qualification of
MOBILE (Mapping of Oxygen By Imaging Lipids Relaxation
Enhancement) as a Hypoxia Imaging Biomarker: Comparison with
EPR Oximetry |
Bernard Gallez,
Ph.D.
Université
Catholique de Louvain
Brussels,
Belgium |
|
|
|
|
|
17:30 |
Dinner |
|
|
|
|
|
|
|
|
Day 3 – Thursday, 21
February 2013
(6.75 CME available) |
|
|
07:00 |
Registration
& Speaker upload available |
|
|
|
|
|
|
08:30 |
Negendank
Lecture: Seeing is Believing? |
Arend Heerschap,
Ph.D.
Radboud University Nijmegen Med Center
Nijmegen, The Netherlands |
|
09:15 |
Break & Speaker
upload available |
|
|
|
|
|
|
|
Session 5: Combining
MR with OMICS Approaches in Cancer Diagnosis & Treatment |
|
|
Moderator:
John D. Hazle, Ph.D. |
|
|
09:30 |
Human Prostate
Cancer: From Metabolomics to Metabolomic Fields |
Leo L. Cheng,
Ph.D.
Massachusetts General Hospital
Charlestown, MA, USA |
|
10:00 |
Expanding
Molecular Imaging Modalities in Cancer Diagnostics: The Role
of Imaging Mass Spectrometry |
Ron M. A. Heeren,
Ph.D.
FOM Institute AMOLF
Amsterdam, The Netherlands |
|
|
|
|
|
|
Oral Session –
Proffered Papers |
|
|
10:30 |
Interplay of
Choline Metabolites & Genes in Patient- Derived Breast
Cancer Xenografts |
Siver A. Moestue,
Ph.D.
Norwegian
University of Science & Technology
Trondheim, Norway |
|
10:45 |
Metabolic
Characterization of Triple Negative Breast Cancer
|
Maria D. Cao,
Ph.D.
Norwegian University of Science & Technology
Trondheim, Norway |
|
11:00 |
Poster Session
(no CME available) |
|
|
|
|
|
|
13:00 |
Lunch & Speaker
upload available |
|
|
|
|
|
|
|
Session 6: Multimodal
MR of the Tumor Vasculature |
|
|
|
Moderator:
Arvind P. Pathak, Ph.D. |
|
|
14:00 |
From Multimodal
to Multiscale: New Paradigms for Visualizing the Tumor
Vasculature
|
Arvind P. Pathak,
Ph.D.
Johns Hopkins School of Medicine
Baltimore, MD, USA |
|
14:30 |
PET & MRI
Assessment of Tumor Microvascular Density
- permission
withheld |
Alexander J. S.
de Crespigny, Ph.D.
Genetech, Inc.
San Francisco, CA, USA |
|
|
|
|
|
|
Oral Session –
Proffered Papers |
|
|
15:00 |
Discrimination
of Angiogenic & Highly Diffuse Infiltrative Brain Tumor
Models Using Multiparametric MRI
- permission
withheld |
Houshang Amiri,
Ph.D.
Radboud University, Nijmegen Medical Centre
Nijmegen, The Netherlands |
|
15:15 |
BOLD MRI – A
Predictive Biomarker of Response to Anti-Angiogenic
Treatment? |
Kirstie S.
Opstad, Ph.D.
St. George’s, University of London
London, England, UK |
|
15:30 |
Break & Speaker
upload available |
|
|
|
|
|
|
|
Session 7: Multimodal
MR of Tumor Metabolism |
|
|
|
Moderator:
Natalie J. Serkova, Ph.D. |
|
|
16:00 |
Multimodal
Imaging Approaches to Visualize Tumor Energy Metabolism |
Sebastián Cerdán,
Ph.D.
Instituto de Investigaciones Biomédicas
Madrid, Spain |
|
|
|
|
|
|
Oral Session –
Proffered Papers |
|
|
16:30 |
Magnetic
Resonance Imaging of Tumor Glycolysis
using Hyperpolarized 13C-Labelled Glucose
- permission
withheld |
Tiago B. Rodrigues,
Ph.D.
Cambridge
Research Institute
Cambridge, England, UK |
|
16:45 |
Evaluation of
Metabolic Biomarkers Associated to PI3K
Inhibition in Breast Cancer Xenografts using HR MAS
MRS |
Siver A. Moestue, Ph.D.
Norwegian
University of Science & Technology
Trondheim, Norway |
|
17:00 |
Quantitative 31P
Magnetic Resonance Spectroscopy Stratifies Treatment
Response to a PI3K/mTOR Inhibitor in Two Distinct Breast
Cancer Xenografts
- permission
withheld |
Morteza Esmaeili,
M.Sc.
Norwegian
University of Science & Technology
Trondheim,
Norway |
|
17:15 |
31P MR
Spectroscopic Imaging in Prostate Cancer Patients at 7T
|
Miriam W.
Lagemaat, M.Sc.
Radboud
University Nijmegen Medical Centre
Nijmegen, The Netherlands |
|
17:30 |
Break & Speaker
upload available |
|
|
|
|
|
|
|
Session 8: Clinical &
Translational Multimodal MR in Cancer |
|
|
|
Moderator:
John C. Gore, Ph.D. |
|
|
18:00 |
Multimodal
Imaging in the Assessment of Treatment Response |
John C. Gore,
Ph.D.
Vanderbilt University
Nashville, TN, USA |
|
|
|
|
|
|
Oral Session –
Proffered Papers |
|
|
18:30 |
DCE-MRI & PET
Imaging of Osteosarcoma During Neoadjuvant Chemotherapy
|
Wilburn E.
Reddick, Ph.D.
St. Jude
Children’s Research Hospital
Memphis, TN, USA |
|
18:45 |
Prostate Cancer
Localization with a Multiparametric MR Approach (PCaMAP):Initial
Results of a Multi-Center Study |
Marnix C. Maas,
Ph.D.
Radboud
University, Nijmegen Medical Centre
Nijmegen, The
Netherlands |
|
19:00 |
Multi-Parametric
Whole Body MRI in Paediatric Lymphoma: Should We Consider
‘Functional’ Quantitative Parameters for Assessment of Nodal
Diseases Status? |
Arash
Latifoltojar, M.B.B.S., M.Sc.
University
College London
London, England,
UK |
|
19:15 |
Diffusion
Weighted MRI & FDG-PET for Laryngeal & Hypopharyngeal
Cancer: Correlation of Apparent Diffusion Coefficient,
Standard Uptake Value & Microanatomy |
Mariëlle
Philippens, M.D., Ph.D.
University
Medical Center Utrecht
Utrecht, The
Netherlands
|
|
|
|
|
|
19:30 |
Dinner |
|
| |
|
|
|
|
|
Day 4 – Friday, 22 February 2013
(3.0 CME available) |
|
|
07:00 |
Registration &
Speaker upload available |
|
|
|
|
|
|
Session 9: Multiparametric MR in Cancer Diagnosis &
Treatment |
|
|
Moderator: Kirstie S. Opstad, Ph.D. |
|
|
08:30 |
Perfusion &
Diffusion Biomarkers for the Evaluation of Brain Cancer
Diagnosis & Treatment |
Kathleen M. Schmainda, Ph.D.
Medical College of Wisconsin
Milwaukee, WI, USA |
|
09:00 |
Multiparametric
MRI: Where Are We in the Clinic? |
Nandita M. DeSouza, M.D., F.R.C.R.
Royal Marsden Hospital
Sutton, Surrey, UK |
|
|
|
|
|
|
Oral Session –
Proffered Papers |
|
|
09:30 |
Diffusion
Weighted & Contrast Enhanced MRI Reveal Response to
PI3-Kinase/mTor Inhibition in Ovarian Xenografts Models
|
Jana Cebulla,
M.Sc.
Norwegian
University of Science & Technology
Trondheim,
Norway |
|
09:45 |
Quantitative
Multi-Parametric Magnetic Resonance Imaging of Ovarian
Cancer |
Patrick J.
Bolan, Ph.D.
University of
Minnesota
Minneapolis, MN, USA |
|
10:00 |
Break & Speaker
upload available |
|
|
|
|
|
|
|
Session 10: Multimodal MR Contrast Agents for Cancer
Detection |
|
|
Moderator:
Mark D. Pagel, Ph.D. |
|
|
10:30 |
The Detection of
Extracellular Cancer Biomarkers with Multi-Agent MRI
|
Mark D. Pagel, Ph.D.
University of Arizona
Tucson, AZ, USA |
|
10:55 |
Tracking
Theranostic Gold Nanostructures with MR & Optical Imaging |
Amit Joshi,
Ph.D.
Baylor College of Medicine
Houston, TX, USA |
|
11:20 |
Imaging
Theranostic CEST MRI/Doxorubicin Liposomes in Mice Bearing
Colon Tumors |
Michael T.
McMahon, Ph.D.
Kennedy Krieger Institute, F.M. Kirby Center
Baltimore, MD, USA |
|
|
|
|
|
|
Oral Session – Proffered Papers |
|
|
11:45 |
Synthesis of a
Complex Multifunctional & Surface- Switchable Nanoemulsion
Platform for Combined Imaging & Therapy |
Willem M. Mulder, Ph.D.
Mount Sinai School of Medicine
New York, NY, USA |
|
|
|
|
|
12:00 |
Adjournment &
Box Lunches |
|
| |
|
|